A PLATELET-ACTIVATING FACTOR (PAF) RECEPTOR ANTAGONIST WHICH INFLUENCES THE PRIMARY PHYSIOLOGICAL-RESPONSES OF RODENTS TO PAF

被引：1
|
作者：
WINSLOW, CM [1 ]
FRISCH, GE [1 ]
DARIES, FJ [1 ]
HANDLEY, DA [1 ]
MELDEN, MK [1 ]
DEACON, RW [1 ]
HOULIHAN, WJ [1 ]
PARRINO, V [1 ]
SCHMITT, G [1 ]
SAUNDERS, RN [1 ]
机构：
[1] SANDOZ RES INST,E HANOVER,NJ 07936
来源：
PROSTAGLANDINS | 1985年 / 30卷 / 04期
关键词：
D O I：
10.1016/0090-6980(85)90042-5
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：698 / 698
页数：1
相关论文
共 50 条
  • [1] Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice
    Ishii, S
    Shimizu, T
    PROGRESS IN LIPID RESEARCH, 2000, 39 (01) : 41 - 82
  • [2] Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF
    Chaithra, Vyala Hanumanthareddy
    Jacob, Shancy Petsel
    Lakshmikanth, Chikkamenahalli Lakshminarayana
    Sumanth, Mosale Seetharam
    Abhilasha, Kandahalli Venkataranganayaka
    Chen, Chu-Huang
    Thyagarajan, Anita
    Sahu, Ravi P.
    Travers, Jeffery Bryant
    McIntyre, Thomas M.
    Kemparaju, Kempaiah
    Marathe, Gopal Kedihithlu
    JOURNAL OF LIPID RESEARCH, 2018, 59 (11) : 2063 - 2074
  • [3] Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist
    Bagnis, C
    Deray, G
    Dubois, M
    Pirotzky, E
    Jacquiaud, C
    Baghos, W
    Aupetit, B
    Braquet, P
    Jacobs, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (03) : 507 - 513
  • [4] THE EFFECT OF PAF-RECEPTOR ANTAGONIST KADSURENONE ON THE CARDIOVASCULAR EFFECTS IN THE RABBIT INFUSED WITH SYNTHETIC PLATELET-ACTIVATING FACTOR (PAF)
    MONTRUCCHIO, G
    ALLOATTI, G
    MARIANO, F
    SHEN, TY
    TETTA, C
    RAGNI, R
    MEDA, E
    EMANUELLI, G
    CAMUSSI, G
    PROSTAGLANDINS, 1985, 30 (04): : 711 - 711
  • [5] Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung
    Uhlig, S
    Göggel, R
    Engel, S
    PHARMACOLOGICAL REPORTS, 2005, 57 : 206 - 221
  • [6] Topical application of a platelet-activating factor (PAF) antagonist in atopic dermatitis
    Abeck, D
    Andersson, T
    Grosshans, E
    Jablonska, S
    Kragballe, K
    Vahlquist, A
    Schmidt, T
    Dupuy, P
    Ring, J
    ACTA DERMATO-VENEREOLOGICA, 1997, 77 (06) : 449 - 451
  • [7] INHIBITION OF PLATELET-ACTIVATING FACTOR (PAF) BINDING TO RABBIT NEUTROPHIL MEMBRANES BY PAF RECEPTOR ANTAGONISTS
    PAULSON, SK
    COX, CP
    FASEB JOURNAL, 1988, 2 (04): : A415 - A415
  • [8] PAF-ACETHER (PLATELET-ACTIVATING FACTOR)
    BENVENISTE, J
    ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1989, 19 : 355 - 358
  • [9] PAF-ACETHER (PLATELET-ACTIVATING FACTOR)
    BENVENISTE, J
    ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1985, 13 : 11 - 18
  • [10] RELEASE OF PLATELET-ACTIVATING FACTOR (PAF) BY MACROPHAGES
    MENCIAHUERTA, JM
    BENVENISTE, J
    ANNALES D IMMUNOLOGIE, 1978, C129 (05): : 754 - 754
12345